These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22763629)

  • 1. Head motion evaluation and correction for PET scans with 18F-FDG in the Japanese Alzheimer's disease neuroimaging initiative (J-ADNI) multi-center study.
    Ikari Y; Nishio T; Makishi Y; Miya Y; Ito K; Koeppe RA; Senda M
    Ann Nucl Med; 2012 Aug; 26(7):535-44. PubMed ID: 22763629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equal sensitivity of early and late scans after injection of FDG for the detection of Alzheimer pattern: an analysis of 3D PET data from J-ADNI, a multi-center study.
    Takahashi R; Ishii K; Senda M; Ito K; Ishii K; Kato T; Makishi Y; Nishio T; Ikari Y; Iwatsubo T;
    Ann Nucl Med; 2013 Jun; 27(5):452-9. PubMed ID: 23483370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apathy as a feature of prodromal Alzheimer's disease: an FDG-PET ADNI study.
    Delrieu J; Desmidt T; Camus V; Sourdet S; Boutoleau-Bretonnière C; Mullin E; Vellas B; Payoux P; Lebouvier T;
    Int J Geriatr Psychiatry; 2015 May; 30(5):470-7. PubMed ID: 24953008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
    Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer's disease.
    Samuraki M; Matsunari I; Chen WP; Yajima K; Yanase D; Fujikawa A; Takeda N; Nishimura S; Matsuda H; Yamada M
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1658-69. PubMed ID: 17520250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant Connectivity in Mild Cognitive Impairment and Alzheimer Disease Revealed by Multimodal Neuroimaging Data.
    Li Q; Wu X; Xie F; Chen K; Yao L; Zhang J; Guo X; Li R;
    Neurodegener Dis; 2018; 18(1):5-18. PubMed ID: 29334684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR-assisted PET motion correction in simultaneous PET/MRI studies of dementia subjects.
    Chen KT; Salcedo S; Chonde DB; Izquierdo-Garcia D; Levine MA; Price JC; Dickerson BC; Catana C
    J Magn Reson Imaging; 2018 Nov; 48(5):1288-1296. PubMed ID: 29517819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atlas-guided non-uniform attenuation correction in cerebral 3D PET imaging.
    Montandon ML; Zaidi H
    Neuroimage; 2005 Mar; 25(1):278-86. PubMed ID: 15734362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative.
    Koppel J; Sunday S; Goldberg TE; Davies P; Christen E; Greenwald BS;
    Am J Geriatr Psychiatry; 2014 Jul; 22(7):698-707. PubMed ID: 23672944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-rater variability of visual interpretation and comparison with quantitative evaluation of
    Yamane T; Ishii K; Sakata M; Ikari Y; Nishio T; Ishii K; Kato T; Ito K; Senda M;
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):850-857. PubMed ID: 27966045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating FDG uptake changes between pre and post therapy respiratory gated PET scans.
    Aristophanous M; Yong Y; Yap JT; Killoran JH; Allen AM; Berbeco RI; Chen AB
    Radiother Oncol; 2012 Mar; 102(3):377-82. PubMed ID: 22265731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modified method of 3D-SSP analysis for amyloid PET imaging using [¹¹C]BF-227.
    Kaneta T; Okamura N; Minoshima S; Furukawa K; Tashiro M; Furumoto S; Iwata R; Fukuda H; Takahashi S; Yanai K; Kudo Y; Arai H
    Ann Nucl Med; 2011 Dec; 25(10):732-9. PubMed ID: 21792587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET of brain amyloid and tau in mild cognitive impairment.
    Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
    N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis based SVM classification enables accurate detection of Alzheimer's disease across different clinical centers using FDG-PET and MRI.
    Dukart J; Mueller K; Barthel H; Villringer A; Sabri O; Schroeter ML;
    Psychiatry Res; 2013 Jun; 212(3):230-6. PubMed ID: 23149027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for motion correction evaluation using 18F-FDG human brain scans on a high-resolution PET scanner.
    Keller SH; Sibomana M; Olesen OV; Svarer C; Holm S; Andersen FL; Højgaard L
    J Nucl Med; 2012 Mar; 53(3):495-504. PubMed ID: 22331217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupled Imaging with [
    Chiaravalloti A; Castellano AE; Ricci M; Barbagallo G; Sannino P; Ursini F; Karalis G; Schillaci O
    Mol Imaging Biol; 2018 Aug; 20(4):659-666. PubMed ID: 29404839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of head movement by frame-to-frame image realignment for receptor imaging in positron emission tomography studies with [
    Ikoma Y; Kimura Y; Yamada M; Obata T; Ito H; Suhara T
    Ann Nucl Med; 2019 Dec; 33(12):916-929. PubMed ID: 31602596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing between scanner differences in multi-center PET studies.
    Joshi A; Koeppe RA; Fessler JA
    Neuroimage; 2009 May; 46(1):154-9. PubMed ID: 19457369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials.
    Iwatsubo T; Iwata A; Suzuki K; Ihara R; Arai H; Ishii K; Senda M; Ito K; Ikeuchi T; Kuwano R; Matsuda H; ; Sun CK; Beckett LA; Petersen RC; Weiner MW; Aisen PS; Donohue MC;
    Alzheimers Dement; 2018 Aug; 14(8):1077-1087. PubMed ID: 29753531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.